Why this $84,000 drug costs just $900 abroad
Gilead Sciences, under fire for pricing a new hepatitis C drug at $1,000 a pill, has discount agreements with a number of health insurers, a company executive said in an interview. The medication, Sovaldi, has a list price of $84,000 for a 12-week course of therapy and is seen as a breakthrough in the treatment of the serious liver disease.
Continue Reading http://www.cnbc.com
Join the Discussion